Home/Filings/8-K/0001213900-26-002350
8-K//Current report

CorMedix Inc. 8-K

Accession 0001213900-26-002350

$CRMDCIK 0001410098operating

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 8:15 AM ET

Size

297.5 KB

Accession

0001213900-26-002350

Research Summary

AI-generated summary of this filing

Updated

CorMedix Inc. Reports Preliminary 2025 Results; CEO Becomes Board Chairman

What Happened

  • CorMedix Inc. announced preliminary financial results for the quarter and year ended December 31, 2025 in a press release dated January 8, 2026; these results are preliminary and subject to completion of audit and accounting procedures and may change.
  • Separately, on January 5, 2026 the company and CEO Joseph Todisco executed an amended and restated executive employment agreement; the Board approved Mr. Todisco’s appointment as Chairman of the Board effective January 8, 2026.

Key Details

  • Preliminary results: press release issued January 8, 2026 (Exhibit 99.1); results are unaudited and subject to adjustment.
  • CEO pay and bonus: Mr. Todisco’s base salary increased from $665,000 to $750,000 effective January 1, 2026; his target annual bonus rose from 65% to 75% of base salary beginning in fiscal 2026.
  • Severance and equity protections: if terminated by the company without Cause (or he leaves for Good Reason), he is eligible for 18 months’ base-salary continuation (or, if within 24 months after a Corporate Transaction, 200% of base salary plus target bonus paid over 24 months), prorated bonus for the year of termination, subsidized COBRA up to 18 months (24 months after a Corporate Transaction), and acceleration of certain unvested equity (with full acceleration if termination occurs within 24 months of a Corporate Transaction).
  • Governance and restrictions: employment agreement includes customary confidentiality, non-disparagement, non-competition and non-solicitation covenants that apply during employment and for 18 months after termination. A separate January 8, 2026 press release announced additional Board and leadership updates (Exhibit 99.2).

Why It Matters

  • Earnings: the preliminary Q4 and full-year results are the most immediate material update for investors; because they are unaudited and subject to change, watch for the finalized figures in audited filings (10-K/10-Q) that may affect valuation and trading.
  • Leadership and governance: the CEO’s elevation to Board Chairman consolidates leadership and may influence strategic direction and investor communication.
  • Compensation and potential cost impact: the higher base salary, larger bonus target and severance protections increase potential near-term and post-termination compensation exposure, which could affect future operating expenses and governance considerations.